Vladimir Khavinson

Vladimir Khavinson is known for the discovery, experimental and clinical studies of new classes of peptide bioregulators as well as for the development of bioregulating peptide therapy. He was engaged in studying of the role of peptides in regulation of the mechanisms of ageing. His main field of actions was design, pre-clinical and clinical studies of new peptide geroprotectors. A 40-year-long investigation resulted in a multitude of methods of application of peptide bioregulators to slow down the process of ageing and increase human life span. Six peptide-based pharmaceuticals and 64 peptide food supplements have been introduced into clinical practice by Khavinson. Patenting endogenous peptides is not a common practice as they are considered a "natural product". He is an author of 196 patents (Russian and international) as well as of 775 scientific publications.
His major achievements are presented in two books: “Peptides and Ageing” (NEL, 2002) and “Gerontological aspects of genome peptide regulation” (Karger AG, 2005).
Vladimir Khavinson introduced scientific specialty "Gerontology and Geriatrics" in the Russian Federation on the governmental level. Academic Council headed by Khavinson oversighted over 200 Ph.D. and Doctorate theses from many countries.
On 26 October 2016, he was awarded the Order of Friendship for his great contribution to the development of healthcare, medical science and many years of conscientious work.
Khavinson died on 6 January 2024, at the age of 77. Provided by Wikipedia